Pam Corona Villalobos

Medicine & Life Sciences

1. Hypertrophic Cardiomyopathy 100%
2. Magnetic Resonance Imaging 59%
3. Acute Kidney Injury 48%
4. Magnetic Resonance Spectroscopy 47%
5. Kidney 47%
6. Pulmonary Arterial Hypertension 46%
7. Coronavirus 43%
8. Hepatocellular Carcinoma 43%
9. Precision Medicine 43%
10. Liver 41%
11. Critical Illness 38%
12. Response Evaluation Criteria in Solid Tumors 36%
13. Survival 27%
14. Neoplasms 26%
15. Pulmonary Hypertension 26%
16. Fibrosis 25%
17. Diffusion Magnetic Resonance Imaging 24%
18. Right Ventricular Function 24%
19. ambrisentan 22%
20. Gadolinium 22%
21. Renal Replacement Therapy 20%
22. Biomarkers 20%
23. Tadalafil 19%
24. Kidney Diseases 18%
25. Therapeutics 18%
26. Biopsy 16%
27. Cholangiocarcinoma 15%
28. Machine Learning 14%
29. Chronic Renal Insufficiency 14%
30. Organ Dysfunction Scores 13%
31. HIV 13%
32. Phenotype 13%
33. Tumor Burden 12%
34. Intensive Care Units 12%
35. Liver Cirrhosis 12%
36. endoplasmic reticulum glycoprotein p72 11%
37. Cardiac Arrhythmias 11%
38. ROC Curve 11%
39. Mortality 11%
40. Exercise 11%
41. osteoblast cadherin 11%
42. Atlases 10%
43. Heart Ventricles 10%
44. Research Ethics Committees 10%
45. Neoplasm Metastasis 10%
46. gadobenic acid 10%
47. Proportional Hazards Models 10%
48. gadolinium ethoxybenzyl DTPA 9%
49. pigment epithelium-derived factor 9%
50. Ventricular Outflow Obstruction 9%